Profile data is unavailable for this security.
About the company
Curatis Holding AG formerly Kinarus Therapeutics Holding AG is a Switzerland-based company that operates in specialty pharmaceutical and therapeutic drug industry. The Company conducts its work within clinical-stage area and focuses on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of diseases. This is done by distributing specialty pharmaceuticals throughout Switzerland, with aims to expanded to larger European markets such as Germany, France, United Kingdom as well as Italy. The drugs and treatments produced are primarily developed in order to treat rare diseases, often referred to as orphan diseases, which receive little funding, relative to more common disorders.
- Revenue in CHF (TTM)10.16m
- Net income in CHF-1.64m
- Incorporated1997
- Employees15.00
- LocationCuratis Holding AGWeierweg 7LIESTAL 4057SwitzerlandCHE
- Phone+41 619278777
- Fax+41 619278775
- Websitehttps://curatis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Darya-Varia Laboratoria Tbk PT | 96.84m | 7.89m | 84.29m | 1.31k | 10.68 | 1.20 | 7.59 | 0.8704 | 154.54 | 154.54 | 1,895.66 | 1,370.50 | 0.9154 | 2.14 | 3.02 | 1,671,758,000.00 | 7.46 | 7.52 | 10.33 | 10.17 | 53.93 | 52.01 | 8.15 | 7.90 | 1.83 | -- | 0.0005 | 57.94 | 10.40 | 2.86 | 6.70 | -6.78 | 11.73 | 0.5546 |
| Lee's Pharmaceutical Holdings Ltd | 141.08m | 9.61m | 85.01m | 1.04k | 8.85 | 0.4454 | 4.30 | 0.6026 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| SynAct Pharma AB | 0.00 | -9.14m | 85.43m | 8.00 | -- | 5.10 | -- | -- | -2.20 | -2.20 | 0.00 | 3.65 | 0.00 | -- | -- | 0.00 | -45.16 | -85.38 | -50.22 | -99.19 | -- | -- | -- | -- | -- | -63.96 | 0.0071 | -- | -- | -- | 61.82 | -- | -- | -- |
| Fortress Biotech Inc | 47.83m | -4.10m | 86.01m | 101.00 | -- | 2.00 | -- | 1.80 | -0.293 | -0.293 | 2.16 | 1.80 | 0.4039 | 1.50 | 4.35 | 616,861.40 | -34.90 | -54.95 | -51.59 | -102.13 | 71.56 | 62.39 | -86.41 | -227.71 | 1.97 | -10.63 | 0.4503 | -- | -31.76 | 9.50 | 18.61 | -- | 25.88 | -- |
| Curatis Holding AG | 10.16m | -1.64m | 88.65m | 15.00 | -- | 1.87 | -- | 8.73 | -0.5733 | -0.5733 | 3.19 | 9.21 | 0.185 | 5.61 | 8.12 | -- | -2.99 | -212.12 | -3.29 | -232.33 | 24.12 | -- | -16.14 | -805.25 | 1.07 | -37.82 | 0.00 | -- | -- | -16.81 | 91.20 | -- | -- | -- |
| BRIM Biotechnology Inc | 71.35k | -9.47m | 91.15m | -- | -- | 2.06 | -- | 1,277.40 | -3.03 | -3.03 | 0.0227 | 13.54 | 0.0017 | -- | 0.2562 | -- | -22.31 | -30.03 | -23.29 | -32.36 | 45.70 | -- | -13,405.20 | -1,623.06 | 27.36 | -1,899.89 | 0.0111 | -- | -75.56 | -- | 54.15 | -- | 310.04 | -- |
| Nang Kuang Pharmaceutical Co Ltd | 54.33m | 6.28m | 91.27m | 552.00 | 14.57 | 1.54 | 8.47 | 1.68 | 2.54 | 2.54 | 21.98 | 24.03 | 0.6073 | 2.19 | 8.36 | -- | 7.02 | 6.64 | 10.08 | 9.56 | 36.34 | 34.50 | 11.56 | 11.94 | 0.7084 | 10.04 | 0.2231 | 80.05 | 2.31 | 4.54 | 22.68 | 2.28 | 52.41 | -1.21 |
| Venture Life Group PLC | 19.41m | -309.10k | 91.50m | 58.00 | -- | 1.20 | 75.21 | 4.71 | -0.0022 | -0.0006 | 0.1454 | 0.5875 | 0.1549 | 1.03 | 1.63 | 319,431.00 | -0.2467 | 0.9986 | -0.271 | 1.16 | 53.34 | 41.69 | -1.59 | 3.38 | 1.41 | 2.01 | 0.2363 | 0.00 | 18.90 | 5.65 | -1,250.00 | -- | -61.25 | -- |
| StemRIM Inc | 0.00 | -9.53m | 91.69m | 45.00 | -- | 2.65 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Arcticzymes Technologies ASA | 8.33m | 618.96k | 92.04m | 55.00 | 152.28 | 3.45 | 69.01 | 11.05 | 0.1464 | 0.1464 | 1.97 | 6.47 | 0.2967 | 0.295 | 1.91 | 1,874,073.00 | 2.20 | 13.28 | 2.32 | 14.39 | 95.42 | 96.20 | 7.43 | 31.41 | 15.45 | -- | 0.0184 | 0.00 | -12.26 | 18.22 | -56.40 | -- | 53.98 | -- |
Data as of Feb 16 2026. Currency figures normalised to Curatis Holding AG's reporting currency: Swiss Franc CHF
0.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 30 Jan 2026 | 8.57k | 0.17% |
| Swiss Life Asset Management AGas of 30 Sep 2025 | 527.00 | 0.01% |
| Banque Cantonale Vaudoise (Investment Management)as of 30 Sep 2025 | 77.00 | 0.00% |
| BlackRock Asset Management Deutschland AGas of 05 Feb 2026 | 33.00 | 0.00% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2025 | 3.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
